본문 바로가기 주메뉴 바로가기

제품소개

제품상세페이지

Others

[eEnzyme] Human Melatonin Receptor 1A (MT1) ACTOne Stable Cell Line

Cat-No. CL-11-MT1

eEnzyme는 다양한 생물에서 단백질 발현을 최적화하는 코돈 최적화 서비스를 제공하는 미국의 Biological 기업입니다.




제품 설명


Human Melatonin Receptor 1A (MT1) ACTOne Stable Cell Line




제품 번호


CL-11-MT1 




제품 특징


Detailed Description


CL-11-MT1

Name

Melatonin Receptor 1A (MT1) ACTOneTM Stable Cell Line

Description

The ACTOne™ MT1 stable cell line is a HEK-293 CNG derivative engineered to express recombinant human melatonin receptor 1A (MT1/MTNR1A). MT1 is primarily coupled to Gi/o proteins; receptor activation inhibits adenylyl cyclase and reduces intracellular cAMP. The assay allows both end-point and kinetic measurement of intracellular cAMP changes with a FLIPR or a fluorescence microplate reader.

Application

cAMP dependent human MT1 cell-based assay;

Cell-based high-throughput screening (HTS) of human MT1 agonists/antagonists

Size

1 mL (frozen cells; 1x 106 cells before freezing)

Detection

FlexStation or Microplate reader

Detection

==>> DATA SHEET      ==>> MSDS



About Human Melatonin Receptor 1A (MT1/MTNR1A) Stable Cell Line

Melatonin Receptor 1A (MTNR1A), commonly known as MT1, is a Class A G protein-coupled receptor (GPCR) activated by the endogenous hormone melatonin. MT1 primarily couples to Gi/o proteins, resulting in inhibition of adenylyl cyclase activity and reduced intracellular cAMP levels. The receptor is expressed in the suprachiasmatic nucleus and other regions of the central nervous system, as well as in several peripheral tissues, where it contributes to circadian rhythm regulation, sleep initiation, endocrine function, and seasonal physiological responses.

MT1 is an important therapeutic target for insomnia, circadian rhythm disorders, mood disorders, and other conditions associated with disrupted melatonin signaling. Pharmacological studies commonly use melatonin receptor agonists and antagonists to investigate receptor activation, selectivity, desensitization, and downstream signaling.

eEnzyme's Human MT1 ACTOne™ Stable Cell Line is a HEK-293 CNG derivative engineered to express recombinant human MTNR1A. Activation of the Gi/o-coupled receptor decreases intracellular cAMP, which can be measured using the ACTOne™ fluorescent reporter system. The assay supports both endpoint and kinetic measurements and is compatible with FLIPR, FlexStation, and fluorescence microplate readers.


Applications

•  MT1 receptor pharmacology studies•  Melatonin signaling research•  Agonist and antagonist screening•  Circadian rhythm and sleep research•  Compound potency and efficacy determination•  cAMP and GPCR functional assays•  High-throughput screening (HTS)•  Drug discovery and lead optimization


Biological Significance of MT1

MT1 is a major mediator of melatonin signaling and plays an important role in synchronizing physiological processes with the light-dark cycle. Through Gi/o-mediated inhibition of cAMP production, MT1 influences neuronal activity, sleep timing, endocrine rhythms, and seasonal biological responses. Altered MT1 expression or signaling has been investigated in sleep disorders, circadian disruption, metabolic dysfunction, and neuropsychiatric conditions.

Because of its central role in melatonin-mediated physiology, MT1 remains an important target for chronobiology, neuroscience, and GPCR-focused drug discovery. The MT1 ACTOne™ Stable Cell Line provides a reliable platform for studying receptor function and evaluating compounds that modulate melatonin signaling.





eEnzyme의 모든 제품을 만나보세요!


Infectious Disease Research Tools

Receptor Stable Cell Lines

Molecular & Cell Biology Reagents

Cell-based Assay Kits

Proteins for Advanced Medicine

Production & Services




eEnzyme - Official Distributor in South Korea "Morebio" 한국 공식 대리점 "모아바이오"